stoxline Quote Chart Rank Option Currency Glossary
  
Akso Health Group (AHG)
2.19  -0.05 (-2.23%)    04-30 16:00
Open: 2.245
High: 2.29
Volume: 162,891
  
Pre. Close: 2.24
Low: 2.17
Market Cap: 207(M)
Technical analysis
2026-04-30 4:23:03 PM
Short term     
Mid term     
Targets 6-month :  2.87 1-year :  3.35
Resists First :  2.46 Second :  2.87
Pivot price 2.17
Supports First :  2.09 Second :  1.87
MAs MA(5) :  2.22 MA(20) :  2.19
MA(100) :  1.72 MA(250) :  1.65
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  66.6 D(3) :  64.8
RSI RSI(14): 55.5
52-week High :  2.5 Low :  1.07
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ AHG ] has closed below upper band by 31.3%. Bollinger Bands are 20% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 2.29 - 2.3 2.3 - 2.31
Low: 2.14 - 2.16 2.16 - 2.17
Close: 2.27 - 2.29 2.29 - 2.31
Company Description

Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, etc. It also offers consultancy and information technology support services; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Beijing, China. As of July 13, 2021, Akso Health Group operates as a subsidiary of Webao Limited.

Headline News

Mon, 27 Apr 2026
AHG Announces Initiation of World-Class, Proprietary Brain-Computer Interface R&D Program - Targeting the Next Frontier of Human Neurotechnology - PR Newswire APAC - PR Newswire Asia

Mon, 27 Apr 2026
Akso Health Group Announces Initiation of Proprietary Brain-Computer Interface Technology Research and Development Program - marketscreener.com

Mon, 20 Apr 2026
How does Akso Health (AHG) stock compare to its competitors (Investor Concern) 2026-04-20 - Crowd Risk Alerts - Cổng thông tin điện tử tỉnh Lào Cai

Mon, 20 Apr 2026
How does Akso Health (AHG) stock compare to its competitors (Investor Concern) 2026-04-20 - Volatility Analysis - UBND thành phố Hải Phòng

Wed, 15 Apr 2026
Why Akso Health Group Shares Are Sliding Now - TipRanks

Mon, 06 Apr 2026
Akso Health Group (AHG) director Xie Zhongliang files initial Form 3 - Stock Titan

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Financial Services
Industry:
Financial - Credit Services
Shares Out 854 (M)
Shares Float 2,570 (M)
Held by Insiders 0 (%)
Held by Institutions 0 (%)
Shares Short 38 (K)
Shares Short P.Month 17 (K)
Stock Financials
EPS -0.48
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.23
Profit Margin 0 %
Operating Margin -20.6 %
Return on Assets (ttm) -1.5 %
Return on Equity (ttm) -68.3 %
Qtrly Rev. Growth 0.8 %
Gross Profit (p.s.) 0
Sales Per Share 0.01
EBITDA (p.s.) -0.01
Qtrly Earnings Growth 0 %
Operating Cash Flow 7 (M)
Levered Free Cash Flow -169 (M)
Stock Valuations
PE Ratio -4.78
PEG Ratio 0
Price to Book value 9.95
Price to Sales 131.78
Price to Cash Flow 269.38
Stock Dividends
Dividend 1.2
Forward Dividend 0
Dividend Yield 52.4%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android